Ocugen’s Gene Therapy Candidates Race Toward FDA Filings, But the Market Isn’t Ready to Celebrate
Ocugen is making quiet but meaningful progress across its pipeline of gene therapy programmes, yet the stock tells a more...
Ocugen is making quiet but meaningful progress across its pipeline of gene therapy programmes, yet the stock tells a more...
Intel’s annual general meeting on May 13 delivered a resounding endorsement of leadership, but the market had already moved on...
For a company that just delivered a 251% jump in revenue and an operating profit of 2.27 billion yen, the...
Take-Two Interactive’s stock is defying a grim financial picture. Shares closed the week at €208.60, up more than 11% in...
ServiceNow shares closed at $95.08 on Friday, up nearly 5%, capping a swift recovery from a midweek slide that dragged...
Alphabet has pulled off the largest Samurai bond ever issued by a non-Japanese company, raising 576.5 billion yen (around $3.6...
Insider buying and a better-than-expected quarterly report have handed QuantumScape’s short sellers an uncomfortable week. With roughly one in six...
The battle lines in the AI chip market are being redrawn at AMD. While the stock has nearly doubled since...
Ocugen has closed a $115 million convertible note offering that buys the biotech group more than two years of operating...
The semiconductor sector has been a study in contradictions this week. Intel sealed a landmark strategic partnership with Nvidia that...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com